CN1475270A - Medicine for treating cancer - Google Patents
Medicine for treating cancer Download PDFInfo
- Publication number
- CN1475270A CN1475270A CNA031499279A CN03149927A CN1475270A CN 1475270 A CN1475270 A CN 1475270A CN A031499279 A CNA031499279 A CN A031499279A CN 03149927 A CN03149927 A CN 03149927A CN 1475270 A CN1475270 A CN 1475270A
- Authority
- CN
- China
- Prior art keywords
- herba
- medicine
- cirsii
- radix
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for treating cancer is prepared from 14 Chinese-medicinal materials including barbat skullcap, stemona root, Herba seai, scorpion, etc. Its advantages are high curative effect, quickly taking its effect, low cost and low by-effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation, especially a kind of medicine that is used for the treatment of.
Background technology
The cancer mortality height, be due to a kind of gene mutation of human body cell, ubiquity one-sidedness aspect the traditional Chinese medical science and western medical treatment cancer at present, limitation and contradiction, radiotherapy as doctor trained in Western medicine, chemotherapy, the treating the poisonous disease with poisonous drugs of the traditional Chinese medical science, in kill cancer cell, also kill normal cell in a large number, caused the situation of " eliminating evil just the change declines ", and activating blood circulation to dissipate blood stasis, resolving the hard mass, as grasp improper then more impel cancerous cell accelerates multiplication and transfer, as import various nutrition to the cancer patient, also provide Basal nutrition simultaneously to cancerous cell, more quicken propagation of cancer cells, because the propagation of cancer cells ability is Normocellular more than 80 times, so form the situation of " setting upright heresy more contains ".
Summary of the invention
The object of the present invention is to provide a kind of effect preferably, be used for cancer medicine.It is by Herba Peperomiae Dindygulensis; Herba Scutellariae Barbatae; Herba Pileae Scriptae; Herba Sedi; Herba Salviae Chinensis; the Radix Stemonae; Radix Cirsii Japonici; Herba Cirsii; Herba Selaginellae Doederleinii; Rhizoma Smilacis Glabrae; Lasiosphaera Seu Calvatia; Scorpio; natural Calculus Bovis and Moschus are formed; be respectively according to each component of its weight ratio: Herba Peperomiae Dindygulensis 40-60 part; Herba Scutellariae Barbatae 40-60 part; Herba Pileae Scriptae 40-60 part; Herba Sedi 40-60 part; Herba Salviae Chinensis 30-50 part; Radix Stemonae 20-40 part; Radix Cirsii Japonici 25-30 part; Herba Cirsii 25-30 part; Herba Selaginellae Doederleinii 20-30 part; Rhizoma Smilacis Glabrae 20-30 part; Lasiosphaera Seu Calvatia 10-20 part; Scorpio 6-12 part; natural Calculus Bovis 0.3-1.0 part and Moschus 0.3-1.0 part; get the raw materials ready respectively, packing gets product behind the uniform mixing.The present invention has following beneficial effect: good effect, and instant effect, cost is low, and side effect is little, and is easy to make.
The specific embodiment
Below in conjunction with embodiment essentiality content of the present invention is described in further detail.
Get Herba Peperomiae Dindygulensis 40 grams, Herba Scutellariae Barbatae 40 grams, Herba Pileae Scriptae 40 grams, Herba Sedi 40 grams, Herba Salviae Chinensis 35 grams, the Radix Stemonae 30 grams, Radix Cirsii Japonici 27 grams, Herba Cirsii 27 grams, Herba Selaginellae Doederleinii 32 grams, Rhizoma Smilacis Glabrae 25 grams, Lasiosphaera Seu Calvatia 15 grams, Scorpio 8 grams, natural Calculus Bovis 0.5 gram and Moschus 0.5 gram according to weight; get the raw materials ready respectively, packing gets product behind the uniform mixing.
Aspect the cause of disease exploration of cancer, environmental factors has become the focus that people pay close attention to, relevant studies show that, Canada is because the improvement of environment, the sickness rate of its pulmonary carcinoma obviously descends, in contrast, the sickness rate of cancers such as developing country's pulmonary carcinoma continue to rise, and with the environmental pollution of developing country direct relation is arranged.In addition, herpesvirus, hepatitis virus, HIV (human immunodeficiency virus) (Human Immunodeficiency Virus), Epstein-Barr virus and Liver fluke, helicobacter pylori etc., closely related with cancers such as hepatocarcinoma, pulmonary carcinoma, gastric cancer, bad life habits, as smoking, indulge in excessive drinking and eating mouldy and smoked, deep-fried food etc., also be the key factor of cause cancer.This medicine can effectively swash in vivo, and antioncogene produces, thereby influence the balance between growth of cancer cells and growth inhibitory signal, adopt toxin expelling mechanism, behind toxin expelling, add the scheme of mending the treatment that combines, make this medicine certain effect be arranged to the treatment cancer, respond well after to part patient medication.
Claims (1)
1. medicine that is used for the treatment of cancer; its characteristic is that it is by Herba Peperomiae Dindygulensis; Herba Scutellariae Barbatae; Herba Pileae Scriptae; Herba Sedi; Herba Salviae Chinensis; the Radix Stemonae; Radix Cirsii Japonici; Herba Cirsii; Herba Selaginellae Doederleinii; Rhizoma Smilacis Glabrae; Lasiosphaera Seu Calvatia; Scorpio; natural Calculus Bovis and Moschus are formed; be respectively according to each component of its weight ratio: Herba Peperomiae Dindygulensis 40-60 part; Herba Scutellariae Barbatae 40-60 part; Herba Pileae Scriptae 40-60 part; Herba Sedi 40-60 part; Herba Salviae Chinensis 30-50 part; Radix Stemonae 20-40 part; Radix Cirsii Japonici 25-30 part; Herba Cirsii 25-30 part; Herba Selaginellae Doederleinii 20-30 part; Rhizoma Smilacis Glabrae 20-30 part; Lasiosphaera Seu Calvatia 10-20 part; Scorpio 6-12 part; natural Calculus Bovis 0.3-1.0 part and Moschus 0.3-1.0 part; get the raw materials ready respectively, packing gets product behind the uniform mixing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA031499279A CN1475270A (en) | 2003-07-31 | 2003-07-31 | Medicine for treating cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA031499279A CN1475270A (en) | 2003-07-31 | 2003-07-31 | Medicine for treating cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1475270A true CN1475270A (en) | 2004-02-18 |
Family
ID=34156399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA031499279A Pending CN1475270A (en) | 2003-07-31 | 2003-07-31 | Medicine for treating cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1475270A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103356957A (en) * | 2013-06-23 | 2013-10-23 | 金国栋 | Medicine for treating stomach cancer and preparation method thereof |
| CN103599237A (en) * | 2013-11-28 | 2014-02-26 | 姜永华 | Traditional Chinese medicine for treating gastric cancer of stasis in stomach collateral type and preparation method thereof |
| CN105709061A (en) * | 2014-12-25 | 2016-06-29 | 倪栽女 | Medicine for treating cancer |
-
2003
- 2003-07-31 CN CNA031499279A patent/CN1475270A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103356957A (en) * | 2013-06-23 | 2013-10-23 | 金国栋 | Medicine for treating stomach cancer and preparation method thereof |
| CN103599237A (en) * | 2013-11-28 | 2014-02-26 | 姜永华 | Traditional Chinese medicine for treating gastric cancer of stasis in stomach collateral type and preparation method thereof |
| CN105709061A (en) * | 2014-12-25 | 2016-06-29 | 倪栽女 | Medicine for treating cancer |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102239972B (en) | Traditional Chinese medicine feed additive used to improve immunity and resist parasitic infection of weaned piglets and preparation and use method thereof | |
| CN103431261B (en) | Special diet suitable for being eaten by patients suffering from deficient and cold spleen and stomach | |
| CN102846866A (en) | Chinese medicine composition for prevention and control of porcine circovirus disease and preparation method thereof | |
| CN103861079A (en) | Traditional Chinese medicine composition with effects of clearing heat, relieving pain and eliminating tumors | |
| Singh et al. | Traditional nutritional and health practices targeting lifestyle behavioral changes in humans | |
| CN103405657B (en) | Medicine for treating cough and preparation method thereof | |
| CN103405631B (en) | For the goods and preparation method thereof of patients with lung cancer | |
| CN109481589A (en) | A kind of preparation method of the toxin expelling anti-cancer capsule for treating lung cancer and dietotherapy anticancer | |
| CN108813610A (en) | A kind of saussurea involucrata composition and its application for improving immunity | |
| CN1475270A (en) | Medicine for treating cancer | |
| CN107095128A (en) | nutrient breakfast | |
| CN106511915B (en) | A kind of compound traditional Chinese medicine composite is inhibiting the application in cutaneous melanoma Lung metastases drug | |
| CN104644683A (en) | American cockroach chewable tablet, preparation method and use | |
| CN104825817B (en) | A kind of Chinese medicine preparation with antitumor action | |
| CN108186794A (en) | A kind of Chinese medicine composition for treating malignant tumour and its preparation method and application | |
| CN107648330A (en) | A kind of hypoglycemic composition based on fennelflower and hypoglycemic anaesthetic | |
| CN104825922B (en) | Chinese medicine composition with anti-colorectal carcinoma activity and its preparation method and application | |
| CN114748603A (en) | Medicine-food homologous composition for preventing and treating new coronavirus pneumonia variation or compound yang and application | |
| CN112516276A (en) | Traditional Chinese medicine for preventing novel coronavirus pneumonia, preparation process thereof and traditional Chinese medicine beverage | |
| CN106421665B (en) | A kind of compound traditional Chinese medicine composite improves the immunity of the human body the application in drug in preparation | |
| CN110393267A (en) | A kind of five cereals solid beverage and preparation method thereof | |
| CN105169327B (en) | A kind of pharmaceutical composition and preparation method thereof for treating porcine diarrhea disease | |
| CN105617319A (en) | Preparation method of traditional Chinese medicine composition for treating acute cholecystitis | |
| CN103610991B (en) | Medicine being used for the treatment of swine gastric ulcer and preparation method thereof | |
| CN104606627B (en) | A kind of pharmaceutical composition for treating grice diarrhoea and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |